Activation of ETS family members in cancer occurs downstream of the RAS/ERK/MEK cascade and DNA binding sites frequently co-exist with binding sites of the AP-1 dimers, which are also activated by RAS/ERK/MEK [7]. This evidence concerns the gene MAP2K7 and cancer.